Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
Apellis Pharmaceuticals (APLS) Ownership Overview
3.99% Insiders
17.52% Mutual Funds
42.22% Other Institutional Investors
21.31% ETFs
14.96% Public Companies and Individual Investors
The ownership structure of Apellis Pharmaceuticals (APLS) stock is a mix of institutional, retail, and individual investors. Approximately 81.05% of the company’s stock is owned by Institutional Investors, 3.99% is owned by Insiders, and 14.96% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 13, 2026 | xxxxxxxxxxxxx | $8151 | |
Jan 23, 2026 | xxxxxxxxxxxxx | $591698 | |
Jan 23, 2026 | xxxxxxxxxxxxx | $73353 | |
Jan 23, 2026 | xxxxxxxxxxxxx | $168096 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $233666 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $3612381 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,329,648 | Institution | 8.08% | 194,920,458 | |
| 9,203,474 | Institution | 7.20% | 173,669,554 | |
| 8,305,688 | Institution | 6.50% | 156,728,333 | |
| 8,174,279 | Institution | 6.39% | 154,248,645 | |
| 4,449,078 | Institution | 3.48% | 83,954,102 | |
| 1,805,259 | Insider | 1.41% | 34,065,237 | |
| 1,433,432 | Institution | 1.12% | 27,048,862 | |
| 1,177,222 | Insider | 0.92% | 22,214,179 | |
| 1,032,374 | Institution | 0.81% | 19,480,897 | |
| 930,800 | Institution | 0.73% | 17,564,196 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,305,688 | Institution | 6.50% | 156,728,333 | |
| 8,174,279 | Institution | 6.39% | 154,248,645 | |
| 1,433,432 | Institution | 1.12% | 27,048,862 | |
| 1,032,374 | Institution | 0.81% | 19,480,897 | |
| 930,800 | Institution | 0.73% | 17,564,196 | |
| 704,552 | Institution | 0.55% | 13,294,896 | |
| 512,728 | Institution | 0.40% | 9,675,177 | |
| 467,487 | Institution | 0.37% | 8,821,480 | |
| 362,905 | Institution | 0.28% | 6,848,017 | |
| 258,867 | Institution | 0.20% | 4,884,820 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,231,737 | Institution | 4.88% | 118,029,099 | |
| 3,394,842 | Institution | 2.66% | 76,655,532 | |
| 2,915,349 | Institution | 2.28% | 53,613,268 | |
| 2,436,655 | Institution | 1.91% | 55,019,670 | |
| 1,354,605 | Institution | 1.06% | 30,586,981 | |
| 1,107,854 | Institution | 0.87% | 25,015,343 | |
| 949,048 | Institution | 0.74% | 17,452,993 | |
| 872,967 | Institution | 0.68% | 16,533,995 | |
| 751,643 | Institution | 0.59% | 14,236,118 | |
| 736,048 | Institution | 0.58% | 13,940,749 |
FAQ
Who Owns Apellis Pharmaceuticals Inc (APLS)?
According to the latest TipRanks data, approximately 42.22% of the company's stock is held by institutional investors, 3.99% is held by insiders, and 14.96% is held by retail investors.
What percentage of Apellis Pharmaceuticals Inc (APLS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 42.22% of Apellis Pharmaceuticals Inc (APLS) stock is held by institutional investors.
What percentage of Apellis Pharmaceuticals Inc (APLS) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.96% of Apellis Pharmaceuticals Inc (APLS) stock is held by retail investors.
Who owns the most shares of Apellis Pharmaceuticals Inc (APLS)?
iShares owns the most shares of Apellis Pharmaceuticals Inc (APLS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.